Integra Lifesciences Holdings (IART) Other Operating Expenses (2009 - 2026)

Integra Lifesciences Holdings has disclosed Other Operating Expenses across 17 years of filings, most recently posting $202.8 million for Q2 2026.

• In Q2 2026, Other Operating Expenses fell 71.89% year-over-year to $202.8 million; the TTM figure through Jun 2026 stood at $798.1 million (down 38.37% YoY), while the FY2025 annual figure was $1.3 billion, changed N/A from the prior year.
• Other Operating Expenses came in at $202.8 million for Q2 2026 at Integra Lifesciences Holdings, up from $178.7 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $721.4 million in Q2 2025 to a low of $644000.0 in Q3 2022.
• Average Other Operating Expenses over 5 years is $214.6 million, with a median of $191.9 million recorded in 2025.
• Year-over-year, Other Operating Expenses jumped 380.0% in 2022 and sank 71.89% in 2026.
• Over 5 years, Other Operating Expenses stood at $644000.0 in 2022, then surged by 27425.93% to $177.3 million in 2023, then advanced by 11.29% to $197.3 million in 2024, then gained by 10.41% to $217.8 million in 2025, then slipped by 6.9% to $202.8 million in 2026.
• Per Business Quant data, the three most recent Other Operating Expenses figures were $202.8 million in Q2 2026, $178.7 million in Q1 2026, and $217.8 million in Q4 2025.